Jessica Gallagher
Family Medicine · Fairborn, OHNPI 1124197793
Payments from drug & device makers
Across 412 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$654
- Otsuka America Pharmaceutical, Inc.$379
- Pfizer$376
- Takeda Pharmaceuticals U.S.A., Inc.$374
- Lilly USA, LLC$331
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,028100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 141 | $1,924 |
| AstraZeneca | 27 | $654 |
| Otsuka America Pharmaceutical, Inc. | 18 | $379 |
| Pfizer | 38 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $374 |
| Lilly USA, LLC | 32 | $331 |
| Amarin Pharma, Inc. | 21 | $322 |
| Merck | 27 | $293 |
| Alkermes, Inc. | 8 | $159 |
| E.r. Squibb & Sons, L.L.C. | 6 | $153 |
| Biohaven Pharmaceuticals, Inc. | 16 | $134 |
| Novo Nordisk | 7 | $112 |
| Amgen | 8 | $110 |
| Boehringer Ingelheim | 6 | $82 |
| GSK | 6 | $79 |
| Lundbeck LLC | 3 | $74 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $72 |
| Avanir Pharmaceuticals, Inc. | 5 | $69 |
| Medtronic | 1 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Indivior Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Braeburn Inc. | 1 | $25 |
| Bayer | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$250
- BREZTRI$212
- Mavyret$124
- TRINTELLIX$117
- UBRELVY$108
How this compares
$6,029 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 47 | $6,692 |
| Aripiprazole | 14 | $1,291 |
| Buprenorphine Hcl | 39 | $1,239 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $1,208 |
| Buspirone Hcl | 44 | $787 |
| Quetiapine Fumarate | 35 | $335 |
| Hydroxyzine Pamoate | 28 | $308 |
| Bupropion XlBupropion Hcl | 20 | $301 |
| Topiramate | 14 | $279 |
| Mirtazapine | 22 | $232 |
| Duloxetine Hcl | 17 | $231 |
| Ibuprofen | 15 | $223 |
| Prazosin Hcl | 15 | $198 |
| Lamotrigine | 17 | $158 |
| Amitriptyline Hcl | 23 | $93 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fairborn
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.